Market Brief: AI Surge, Netflix Slump, Crypto Squeeze

Opening Recap

Market Pulse: Risk assets edged lower as Netflix’s merger hopes fizzled and crypto wobbled around Bitcoin’s tight range.

Key Movers: Netflix shares slid to multi-month lows after rumors of deals with Roku and Warner Bros. evaporated; Bitcoin traders braced for a potential short squeeze; chip and cloud names shrugged off Iran and Fed concerns thanks to AI-driven buying.

Macro & Politics: Supreme Court’s rejection of Trump’s “Right to Try” claim reminds us political theater won’t translate into biotech breakthroughs—real catalysts come from FDA approvals.

What’s Next: Watch Fed speeches on inflation chatter and the ramp-up of earnings season for fresh market drivers.

Market Commentary

What everyone’s missing is that the AI spending spree highlighted by Wolfe Research’s Stephanie Roth doesn’t end when chip stocks run out of steam. Yes, algorithms don’t blink at sanctions, but companies can. Weeks of ETF outflows for Bitcoin show it’s not just tech stocks flirting with exhaustion. A misstep in capex budgeting could leave major players nursing busted projects and equity traders nursing losses faster than you can say “bear market.”

Consider the silent link between Netflix’s merger duds and the Supreme Court’s smackdown of Trump’s Right to Try claim. Both stories are cautionary tales about the gap between bluster and substance. Investors banking on courtroom stunts instead of FDA sign-offs or hanging onto the promise of blockbuster deals will end up holding empty envelopes.

If you want to make money, don’t chase fluff—zero in on companies with concrete catalysts. Track FDA approvals in biotech, upcoming earnings beats in chip and cloud names riding the AI wave, and keep an eye on Bitcoin’s squeeze levels above $63,500. That’s where opportunities lie; everything else is noise.